Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4
van den Bulk, Jitske, Verdegaal, Els M E, Ruano, Dina, Ijsselsteijn, Marieke E, Visser, Marten, van der Breggen, Ruud, Duhen, Thomas, van der Ploeg, Manon, de Vries, Natasja L, Oosting, Jan, Peeters, Koen C M J, Weinberg, Andrew D, Farina-Sarasqueta, Arantza, van der Burg, Sjoerd H, de Miranda, Noel F C C
Published in Genome medicine (30.12.2019)
Published in Genome medicine (30.12.2019)
Get full text
Journal Article
Successful treatment of metastatic melanoma by adoptive transfer of blood-derived polyclonal tumor-specific CD4+ and CD8+ T cells in combination with low-dose interferon-alpha
Verdegaal, Els M. E., Visser, Marten, Ramwadhdoebé, Tamara H., van der Minne, Caroline E., van Steijn, Jeanne A. Q. M. J., Kapiteijn, Ellen, Haanen, John B. A. G., van der Burg, Sjoerd H., Nortier, Johan W. R., Osanto, Susanne
Published in Cancer Immunology, Immunotherapy (01.07.2011)
Published in Cancer Immunology, Immunotherapy (01.07.2011)
Get full text
Journal Article
Genome‐wide promoter methylation analysis identifies epigenetic silencing of MAPK13 in primary cutaneous melanoma
Gao, Linda, Smit, Marjon A., den Oord, Joost J., Goeman, Jelle J., Verdegaal, Els M. E., Burg, Sjoerd H., Stas, Marguerite, Beck, Samuel, Gruis, Nelleke A., Tensen, Cornelis P., Willemze, Rein, Peeper, Daniel S., Doorn, Remco
Published in Pigment cell and melanoma research (01.07.2013)
Published in Pigment cell and melanoma research (01.07.2013)
Get full text
Journal Article
Potential use of lymph node-derived HPV-specific T cells for adoptive cell therapy of cervical cancer
van Poelgeest, Mariëtte I. E., Visconti, Valeria V., Aghai, Zohara, van Ham, Vanessa J., Heusinkveld, Moniek, Zandvliet, Maarten L., Valentijn, A. Rob P. M., Goedemans, Renske, van der Minne, Caroline E., Verdegaal, Els M. E., Trimbos, J. Baptist M. Z., van der Burg, Sjoerd H., Welters, Marij J. P.
Published in Cancer Immunology, Immunotherapy (01.12.2016)
Published in Cancer Immunology, Immunotherapy (01.12.2016)
Get full text
Journal Article
Near-genomewide RNAi screening for regulators of BRAFV600E-induced senescence identifies RASEF, a gene epigenetically silenced in melanoma
Kaplon, Joanna, Hömig-Hölzel, Cornelia, Gao, Linda, Meissl, Katrin, Verdegaal, Els M. E., van der Burg, Sjoerd H., van Doorn, Remco, Peeper, Daniel S.
Published in Pigment cell and melanoma research (01.07.2014)
Published in Pigment cell and melanoma research (01.07.2014)
Get full text
Journal Article
Cancer immunotherapy: broadening the scope of targetable tumours
van den Bulk, Jitske, Verdegaal, Els ME, de Miranda, Noel FCC
Published in Open biology (01.06.2018)
Published in Open biology (01.06.2018)
Get full text
Journal Article
IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma
Melief, Sara M., Visser, Marten, van der Burg, Sjoerd H., Verdegaal, Els M. E.
Published in Cancer Immunology, Immunotherapy (01.07.2017)
Published in Cancer Immunology, Immunotherapy (01.07.2017)
Get full text
Journal Article
PRAME and CTCFL-reactive TCRs for the treatment of ovarian cancer
van Amerongen, Rosa A, Tuit, Sander, Wouters, Anne K, van de Meent, Marian, Siekman, Sterre L, Meeuwsen, Miranda H, Wachsmann, Tassilo L A, Remst, Dennis F G, Hagedoorn, Renate S, van der Steen, Dirk M, de Ru, Arnoud H, Verdegaal, Els M E, van Veelen, Peter A, Falkenburg, J H Frederik, Heemskerk, Mirjam H M
Published in Frontiers in immunology (21.03.2023)
Published in Frontiers in immunology (21.03.2023)
Get full text
Journal Article
Simplified Monopalmitoyl Toll‐like Receptor 2 Ligand Mini‐UPam for Self‐Adjuvanting Neoantigen‐Based Synthetic Cancer Vaccines
Ende, Thomas C., Heuts, Jeroen M. M., Gential, Geoffroy P. P., Visser, Marten, Graaff, Michel J., Ho, Nataschja I., Jiskoot, Wim, Valentijn, A. Rob P. M., Meeuwenoord, Nico J., Overkleeft, Herman S., Codée, Jeroen D. C., Burg, Sjoerd H., Verdegaal, Els M. E., Marel, Gijsbert A., Ossendorp, Ferry, Filippov, Dmitri V.
Published in Chembiochem : a European journal of chemical biology (06.04.2021)
Published in Chembiochem : a European journal of chemical biology (06.04.2021)
Get full text
Journal Article
CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden
van den Bulk, Jitske, van der Ploeg, Manon, Ijsselsteijn, Marieke E, Ruano, Dina, van der Breggen, Ruud, Duhen, Rebekka, Peeters, Koen C M J, Fariña-Sarasqueta, Arantza, Verdegaal, Els M E, van der Burg, Sjoerd H, Duhen, Thomas, de Miranda, Noel F C C
Published in Journal for immunotherapy of cancer (01.02.2023)
Published in Journal for immunotherapy of cancer (01.02.2023)
Get full text
Journal Article
Autoantibody-positivity before and seroconversion during treatment with anti-PD-1 is associated with immune-related adverse events in patients with melanoma
Borgers, Jessica S W, van Wesemael, Tineke J, Gelderman, Kyra A, Rispens, Theo, Verdegaal, Els M E, Moes, Dirk J A R, Korse, Catharina M, Kapiteijn, Ellen, Welters, Marij J P, van der Burg, Sjoerd H, van Houdt, Winan J, van Thienen, Johannes V, Haanen, John B A G, van der Woude, Diane
Published in Journal for immunotherapy of cancer (30.06.2024)
Published in Journal for immunotherapy of cancer (30.06.2024)
Get full text
Journal Article
Timed adoptive T cell transfer during chemotherapy in patients with recurrent platinum-sensitive epithelial ovarian cancer
Verdegaal, Els M E, Santegoets, Saskia J, Welters, Marij J P, de Bruin, Linda, Visser, Marten, van der Minne, Caroline E, de Kok, Pita M, Loof, Nikki M, Boekestijn, Sanne, Roozen, Inge, Westra, Inge M, Meij, Pauline, Van der Burg, Sjoerd H, Kroep, Judith R
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
Phase I/II study protocol to assess safety and efficacy of adoptive cell therapy with anti-PD-1 plus low-dose pegylated-interferon-alpha in patients with metastatic melanoma refractory to standard of care treatments: the ACTME trial
van der Kooij, Monique K, Verdegaal, Els M E, Visser, Marten, de Bruin, Linda, van der Minne, Caroline E, Meij, Pauline M, Roozen, Inge C F M, Jonker, Mare A, van den Bosch, Shelley, Liefers, Gerrit-Jan, Speetjens, Frank M, van der Burg, Sjoerd H, Kapiteijn, Ellen
Published in BMJ open (24.11.2020)
Published in BMJ open (24.11.2020)
Get full text
Journal Article
Blood-based kinase activity profiling: a potential predictor of response to immune checkpoint inhibition in metastatic cancer
Hurkmans, Daan P, Verdegaal, Els M E, Hogan, Sabrina A, de Wijn, Rik, Hovestad, Lies, van den Heuvel, Dianne M A, Ruijtenbeek, Rob, Welters, Marij J P, van Brakel, Mandy, Basak, Edwin A, Pinedo, Herbert M, Lamers, Cor H J, van de Werken, Harmen J G, Groten, John P, Debets, Reno, Levesque, Mitchell P, Dummer, Reinhard, Kapiteijn, Ellen, Mathijssen, Ron H J, Aerts, Joachim G J V, van der Burg, Sjoerd H
Published in Journal for immunotherapy of cancer (01.12.2020)
Published in Journal for immunotherapy of cancer (01.12.2020)
Get full text
Journal Article
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4+ T cells in human melanoma
Linnemann, Carsten, van Buuren, Marit M, Bies, Laura, Verdegaal, Els M E, Schotte, Remko, Calis, Jorg J A, Behjati, Sam, Velds, Arno, Hilkmann, Henk, Atmioui, Dris el, Visser, Marten, Stratton, Michael R, Haanen, John B A G, Spits, Hergen, van der Burg, Sjoerd H, Schumacher, Ton N M
Published in Nature medicine (01.01.2015)
Published in Nature medicine (01.01.2015)
Get full text
Journal Article
Neoantigen landscape dynamics during human melanoma–T cell interactions
Verdegaal, Els M. E., de Miranda, Noel F. C. C., Visser, Marten, Harryvan, Tom, van Buuren, Marit M., Andersen, Rikke S., Hadrup, Sine R., van der Minne, Caroline E., Schotte, Remko, Spits, Hergen, Haanen, John B. A. G., Kapiteijn, Ellen H. W., Schumacher, Ton N., van der Burg, Sjoerd H.
Published in Nature (London) (04.08.2016)
Published in Nature (London) (04.08.2016)
Get full text
Journal Article
Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S
Harryvan, Tom J, Visser, Marten, de Bruin, Linda, Plug, Léonie, Griffioen, Lisa, Mulder, Arend, van Veelen, Peter A, van der Heden van Noort, Gerbrand J, Jongsma, Marlieke LM, Meeuwsen, Miranda H, Wiertz, Emmanuel JHJ, Santegoets, Saskia J, Hardwick, James CH, Van Hall, Thorbald, Neefjes, Jacques, Van der Burg, Sjoerd H, Hawinkels, Lukas JAC, Verdegaal, Els ME
Published in Journal for immunotherapy of cancer (01.03.2022)
Published in Journal for immunotherapy of cancer (01.03.2022)
Get full text
Journal Article